Genetic associations with human longevity at the APOE and ACE loci

Nature Genetics

Volumn 6, Issue 1, 1994, Pages 29-32

  Schächter, Franҫois ^a   Faure Delanef, Laurence ^a   Guénot, Frédérique ^a   Rouger, Hervé ^a   Froguel, Philippe ^a   Lesueur Ginot, Laurence ^a   Cohen, Daniel ^a  

^a FONDATION JEAN DAUSSET CEPH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LONGEVITY; MALE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEINS E; BASE SEQUENCE; CASE-CONTROL STUDIES; FEMALE; FRANCE; GENE FREQUENCY; GENOTYPE; HUMAN; LONGEVITY; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM (GENETICS); SEX CHARACTERISTICS;

EID: 0028359655     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng0194-29     Document Type: Article

References (36)

1. Abbott, M. H., Murphy, E. A., Bolling, D. R. & Abbey, H. The familial component in longevity, a study of the offspring of nonagenarians II. Preliminary analysis of the completed study. Johns Hopkins med. J. 134, 1-16 (1974).
2. Finch, C. E. Genetic influences on lifespan, mortality rates, and age-related diseases. In Longevity, senescence and the genome, p. 298-352 (University of Chicago Press, Chicago, 1990).
3. Schächter, F. & Cohen, D. Longevity: a new field for human genetics. Lifespan 4, 1-3 (1993).
4. Schächter, F., Cohen, D. & Kirkwood, T. B. L. Prospects for the genetics of human longevity. Human Genetics 91, 519-526 (1993).
5. Proust, J. et al. HLA and longevity. Tissue Antigens 19, 168-173 (1982).
6. Takata, H., Ishii, T., Suzuki, M., Sekiguchi, S. & Iri, H. Influence of major histocompatibllity complex region genes on human longevity among Okinawan-Japanese centenarians and nonagenarians. Lancet ii, 824-826 (1987).
7. Hatton, F. & Michel, E. Les causes de mortalité en 1990. Insee première 196, mai 1992.
8. Zannis, I. et al. Proposed nomenclature of apoE isoproteins, apoE genotypes and phenotypes. J. lipid Res. 23, 911-914 (1982).
9. Davignon, J., Gregg, R. E. & Sing, C. F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8, 1-21 (1988).
10. Van Bockxmeer, F. M. & Mamotte, C. D. S. Apolipoprotein ε 4 homozygosity in young men with coronary heart disease. Lancet 340, 879-880 (1992).
11. Eto, M., Watanabe, K. & Makino, I. Increased frequencies of apolipoprotein ε2 and ε4 alleles In patients with ischemic heart disease. Clin. Genet. 36, 183-188 (1989).
12. Tiret, L. et al. Evidence, from combined segregation and linkage anylysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am. J. hum. Genet. 51, 197-205 (1992).
13. Cambien, F. et al. Deletion polymorphism in the gene coding for angiotensin-oonverting enzyme is a potent risk factor for myocardial infarction. Nature 359, 641-644 (1992).
14. Tiret, L. et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 341, 991-992 (1993).
15. Hixson, J. E. & Vernier, D. T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J. lipid Res. 31, 545-548 (1990).
16. Rigat, B., Hubert, C., Corvol, P. & Soubrier, F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene. Nucl. Acids Res. 20, 1433 (1992).
17. Bailleul, S. et al. Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France). Hum. Hered. 43, 159-165 (1993).
18. Boerwinkle, E., Lee, S. S., Butler, R., Schumaker, V. N. & Chan, L. Rapid typing of apolipoprotein BDNA polymorphisms by DNA amplification. Atherosclerosis 81, 225 (1990).
19. Peacock, R. et al. Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: A study of young myocardial infarction survivors and healthy population-based individuals. Atherosclerosis 92, 151-164 (1992).
20. Andrew, S. et al. Nonrandom association between Huntington disease and two loci separated by about 3 Mb on 4p16. 3. Genomics 13, 301-311 (1992).
21. Weber, J. L. & May, P. E. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am. J. hum. Genet. 44, 388-396 (1989).
22. Fries, J. F. Aging, natural death and the compression of morbidity. New Engl. J. Med. 303, 130 (1980).
23. Ordovas, J. M., Litwack-Klein, L., Wilson, P. W. F., Schaefer, M. M. & Schaefer, E. J. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J. lipid Res. 28, 371-380 (1987).
24. Utermann, G., Steinmetz, A. & Weber, W. Genetic control of human apolipoprotein E polymorphism: comparison one-and two-dimensionai techniques of isoprotein analysis. Hum. Genet. 60, 344-351 (1982).
25. Boemi, M. et al. Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies. Diabetologia 36, 229-233 (1993).
26. Jeunemaître, X., Lifton, R. P., Hunt, S. C., Williams, R. R. & Lalouel, J. M. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet. 1, 72-75 (1992).
27. Ehlers, M. R. W. & Riordan, J. F. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 28, 5311-5313 (1989).
28. Costerousse, O., Jaspard, E., Wei, L., Corvol, P. & Alhene-Gelas, F. The angiotensin I-converting enzyme (kininase II): molecular organization and regulation of its expression in humans. J. cardiovasc. Pharmacol. 20(suppl. 9), S10-S15 (1992).
29. McGeer, E. G. & Singh, E. A. Angiotensin-converting enzyme in cortical tissue in Alzheimer’s and some other neurological diseases. Dementia 3, 299-303 (1992).
30. Eisenlohr, L. C., Bacik, I., Bennink, J. R., Bernstein, K. & Yewdell, J. W. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell 71, 963-972 (1992).
31. Jorgensen, J. O. L. & Christiansen, J. S. Brave new senescence: GH therapy in adults. Lancet 341, 1247 (1993).
32. Donald, J. A. et al. Linkage relationships of the gene for apolipoprotein CII with loci on chromosome 19. Hum. Genet. 69, 39-43 (1985).
33. Strittmatter, W. J. et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. natn Acad. Sci. U. S. A. 90, 1977-1981 (1993).
34. Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921-923 (1993).
35. Skoog, I., Nilsson, L., Palmertz, B., Andreasson, L. A., Svanborg, A. A population-based study of dementia in 85-year-olds. New Engl. J. Med. 328, 153-158 (1993).
36. Kirkwood, T. B. L. & Rose, M. R. Evolution of senescence: late survival sacrificed for reproduction. Phil. Trans. R. Soc. Lond. B 332: 15-24 (1991).